Avadel Pharmaceuticals plc - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AVDL Nasdaq 2830 www.avadel.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avadel Pharmaceuticals plc

ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders - Jul 14th, 2025 5:00 am
Avadel Pharmaceuticals Receives Unanimous Appeals Court Affirmation for LUMRYZ FDA Approval - Jul 10th, 2025 9:40 am
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - Jul 7th, 2025 5:42 am
Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation - Jun 30th, 2025 5:00 am
Avadel Shareholder Seeks Ousting Drugmaker’s Entire Board - Jun 29th, 2025 7:00 pm
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Jun 16th, 2025 2:05 pm
Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High? - Jun 16th, 2025 7:55 am
Surging Earnings Estimates Signal Upside for Avadel (AVDL) Stock - Jun 13th, 2025 10:20 am
Following a 34% decline over last year, recent gains may please Avadel Pharmaceuticals plc (NASDAQ:AVDL) institutional owners - Jun 10th, 2025 5:29 am
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia - Jun 5th, 2025 5:30 am
Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025 - May 29th, 2025 10:06 pm
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025 - May 29th, 2025 2:05 pm
Wall Street Analysts Think Avadel (AVDL) Could Surge 97.68%: Read This Before Placing a Bet - May 29th, 2025 7:55 am
Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - May 29th, 2025 6:00 am
All You Need to Know About Avadel (AVDL) Rating Upgrade to Buy - May 15th, 2025 10:00 am
Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer - May 13th, 2025 2:15 pm
Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference - May 13th, 2025 6:00 am
Earnings Estimates Moving Higher for Avadel (AVDL): Time to Buy? - May 12th, 2025 10:20 am
Wall Street Analysts Believe Avadel (AVDL) Could Rally 100.21%: Here's is How to Trade - May 12th, 2025 7:55 am
Analysts Are Updating Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates After Its First-Quarter Results - May 10th, 2025 6:56 am